London, 17 September. ORPHEUS vice-president represents ORPHEUS at conference on the future of the UK PhD arranged by the Society of Biology, the Biochemical Society and the British Pharmacological Society. Participants included representatives for UK graduate schools as well as representatives for BBSRC, QAA, MRC, Wellcome Trust, HEFCE, the Biochemical Society, the British Pharmacological Society, the Society of Biology. The purpose of the conference was to discuss the UK PhD in the light of developments in PhD training in Continental Europe. Topics included: What are the advantages to the UK PhD training model? Are there any disadvantages?; Do Biomedical PhD’s require their own standards distinct from other PhD’s e.g. physics?; How do the UK PhD training schemes match the ORPHEUS model?; Are there any other available models e.g. LERU guideline?; What advantages would standardisation bring?; What type of training should we be offering PhD students?; How do we ensure the quality of the PhD? E.g. untrained examiners; Are there any improvements to be made to current programmes?; How do organisations use their PhD programmes strategically?; What roles does industry play in PhD training?